new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Filing Names

Astrazeneca Uk Limited
Astrazeneca Uk Limited Ab

Astrazeneca Uk Limited patents

Recent patent applications related to Astrazeneca Uk Limited. Astrazeneca Uk Limited is listed as an Agent/Assignee. Note: Astrazeneca Uk Limited may have other listings under different names/spellings. We're not affiliated with Astrazeneca Uk Limited, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Astrazeneca Uk Limited-related inventors

Date Astrazeneca Uk Limited patents (updated weekly) - BOOKMARK this page
11/10/16Pharmaceutical compositions comprising azd9291
05/12/16Systems for allowing annotation in real time
03/24/16A nk3 receptor antagonist compound (nk3ra) for use in a the treatment of polycystic ovary syndrome (pcos)
01/14/16Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-phthalazin-1-one
08/27/15Bilayer tablet formulations
06/04/15Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition
04/16/15Inhaler counter
10/02/14Pharmaceutical composition of rosuvastatin calcium
10/02/14Trisubstituted triazolopyrimidines for use in platelet aggregation inhibiton
05/29/14Novel ticagrelor co-crystal
08/29/13Crystalline form of bis[(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid] calcium salt
02/14/13Novel compound
12/20/12Pharmaceutical composition
12/08/11Process for the manufacture of the calcium salt of rosuvastatin (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]-pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid and crystalline intermediates thereof
03/31/11Method for treating and preventing kidney stones employing an sglt2 inhibitor and composition containing same
03/31/11Method for treating hyponatremia employing an sglt2 inhibitor and composition containing same
01/20/11Method for treating cancers having high glucose requirements employing an sglt2 inhibitor and compositions thereof
10/14/10Targeted binding agents directed to kdr and uses thereof - 035
10/07/10Methods for preventing or reducing risk of mortality
08/19/10Process for the preparation of dihydroxy esters and derivatives thereof
11/12/09Novel thiazolo (4,5-d) pyrimidine compounds novel compounds
10/22/09Process for the preparation of pyrimidine compounds
06/04/092,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
06/24/10Heteroarylcarbamoylbenzene derivatives for the treatment of diabetes

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Astrazeneca Uk Limited in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Astrazeneca Uk Limited with additional patents listed. Browse our Agent directory for other possible listings. Page by